Sort   by:  
 Page size 
TranscriptomicsTranscriptional profiling of staurosporine-induced cell death in wild type versus M-NM-^Tczt-1 in Neurospora crassa
Purpose: Compare the transcriptional profile of staurosporine-treated cells in Neurospora crassa wild type and M-NM-^Tczt-1 (M-NM-^TNCU09974) cells Methods: Conidial suspensions were obtained and 1 x 106 cells/ml incubated in minimal medium for 6 hours (26M-BM-:C, 140 rpm, constant light) followed b...
ORGANISM(S): Neurospora crassa 
2014-07-01 | E-GEOD-52153 | biostudies-arrayexpress
TranscriptomicsNeurospora crassa wild-type cells (WT, FGSC 2489) undergoing a time-course treatment with staurosporine
Staurosporine induces programmed cell death in a series of organisms. Here, we analyse gene expression of the filamentous fungus Neurospora crassa following exposure to staurosporine for different time periods. Cells incubated for 15, 30, 60 and 120 min in the presence (S) or absence (C) of staurosp...
ORGANISM(S): Neurospora crassa 
2011-09-29 | E-GEOD-32451 | biostudies-arrayexpress
Transcriptomicssmall RNA Next Generation Sequencing of human primary macrophages treated with staurosporine
Human primary macrophages were treated with 1 µM staurosporine (STS) and profiled for small RNAs. Human primary macrophages were treated with 1 µM staurosporine (STS) for 0, 4 and 6h.
ORGANISM(S): Homo sapiens 
2015-09-16 | E-GEOD-47608 | biostudies-arrayexpress
TranscriptomicsTranscriptional profiling of staurosporine-induced cell death in Vogel's minimal medium with different concentrations of calcium
Purpose: Compare the transcriptional profile of staurosporine-treated cells in Neurospora crassa wild type cells grown with different availabilities of calcium. Methods: Conidial suspensions were obtained and 1 x 106 cells/ml incubated in minimal medium (with the indicated concentrations of calcium)...
ORGANISM(S): Neurospora crassa 
2014-12-05 | E-GEOD-53013 | biostudies-arrayexpress
ProteomicsQuantitative Top-Down Proteomics Revealed Staurosporine-induced Proteoform-level Changes in Cancer Cells
We conducted a quantitative top-down proteomics analysis on HeLa cells treated with staurosporine to investigate differential expression of proteoforms. Furthermore, we assessed alterations in phosphorylation patterns for intact phosphoproteoforms
ORGANISM(S): Homo sapiens (Human) 
2025-01-31 | PXD048148 | Pride
Proteomics Hela Phosphorylation Quantitative Top-down Staurosporine 
TranscriptomicsNeurospora crassa wild-type cells (WT, FGSC 2489) undergoing a time-course treatment with staurosporine
Staurosporine induces programmed cell death in a series of organisms. Here, we analyse gene expression of the filamentous fungus Neurospora crassa following exposure to staurosporine for different time periods.
ORGANISM(S): Neurospora crassa 
2011-09-30 | GSE32451 | GEO
UnknownStaurosporine Analogs Via C-H Borylation.
Not available
S-EPMC7734790 | biostudies-literature
ProteomicsData and Information collection on 3 normal rat kidney epithelial cells treated with staurosporine
3 normal rat kidney epithelial cells treated with staurosporine,LC-MS/MS.
ORGANISM(S): Rattus norvegicus (Rat) 
2023-10-19 | PXD039380 | Pride
Lc-ms/ms Normal rat kidney epithelial cells 
Genomicssmall RNA Next Generation Sequencing of human primary macrophages treated with staurosporine
Human primary macrophages were treated with 1 µM staurosporine (STS) and profiled for small RNAs.
ORGANISM(S): Homo sapiens 
2015-09-16 | GSE47608 | GEO
TranscriptomicsShigella Apoptosis Arrays
Array data from HeLa cells that remained Uninfected or were infected with wildtype S. flexneri serotype 2a strain 2457T. These groupings are further divided such that Uninfected or Infected cells remained untreated or were treated with the apopotosis inducer staurosporine (STS). The design of the ...
ORGANISM(S): Homo sapiens 
2010-06-12 | E-GEOD-22287 | biostudies-arrayexpress
Sort   by:  
 Page size